Synthekine Presents Preclinical Data at SITC 38th Annual Mee

Synthekine Presents Preclinical Data at SITC 38th Annual Meeting Demonstrating its IL-12 Partial Agonist, STK-026, Significantly Expands Therapeutic Window

Synthekine Presents Preclinical Data at SITC 38th Annual Meeting Demonstrating its IL-12 Partial Agonist, STK-026, Significantly Expands Therapeutic Window

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

San Diego , California , United States , , Linkedin , Synthekine Inc , Twitter , Society For Immunotherapy Of Cancer , Annual Meeting , Martin Oft , Preclinical Pharmacodynamic Characterization , Improved Therapeutic Window , Immune Modulators , Board Number , Key Findings ,